http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101227434-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101227434-B1 |
| titleOfInvention | Peptides targeting CD4 protein, a breast cancer stem cell specific marker, and use thereof |
| abstract | The present invention relates to a CD44 targeting peptide, which is a breast cancer stem cell specific marker, and a cancer diagnostic kit using the same. Peptides according to the present invention can be used as a low molecular diagnostic probe for diagnosing the expression of breast cancer cells and drug delivery material for the treatment and prevention of cancer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101520672-B1 |
| priorityDate | 2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 215.